Table 4

Base case analysis: life expectancy, quality adjusted life expectancy, and direct lifetime costs discounted at 3% (rounded values).

No antiviral treatmentInterferon plus ribavirinPeginterferon plus fixed ribavirinPeginterferon plus weight based ribavirin
Costs ()14 10019 30021 80022 400
Life expectancy (y) 17.0 18.6 18.8 19.1
Quality-adjusted life expectancy (QALY) 15.1 16.8 17.0 17.3